Erica Mann has experience and understanding of complementary medicines and naturopathic principles. She also has experience in over-the-counter health care products, and has worked in leadership roles in organisations at the head of health technology developments.
Ms Mann has worked in highly regulated, complex multi-channel and multi-product environments across multiple jurisdictions. She has significant experience in both small- & large-scale health related M&A and integration, and a deep expertise in extracting strategy from health trends with a strong focus on culture, risk management and ESG.
Ms Mann was the president & head of Bayer's global consumer health division where she directed every aspect of consumer self-care companies globally. She had also held executive positions on the boards of South African Pharmaceutical Manufacturers' Association, Medicines Australia and the International Association of Infant Food Manufacturers.
Ms Mann was chair of the World Self-Medication Industry, a body that sets standards and guidelines for the design and labelling of non-prescription medicines and dietary supplements.
